An exercise in divide and rule in the healthcare market
This article was originally published in Clinica
Allergan is to concentrate exclusively on Botox and its other pharma applications, leaving the medical device-oriented eye surgery and contact lens businesses to be developed as a spin-off company, Advanced Medical Optics. AMO chief executive Jim Mazzo takes a break from a breathless six-month schedule of company building to outline his plans to Ashley Yeo
You may also be interested in...
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.